LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.39 | 770.25 | 6985 | 9326 | 0.7490 | 0.8456 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.39 | 770.25 | 8397 | 9326 | 0.9004 | 0.9425 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.61 | 770.25 | 7153 | 9736 | 0.7347 | 0.8384 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.61 | 770.25 | 8894 | 9736 | 0.9135 | 0.9512 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.83 | 770.25 | 7465 | 10078 | 0.7407 | 0.8446 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.83 | 770.25 | 9220 | 10078 | 0.9148 | 0.9526 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.05 | 770.25 | 7828 | 10413 | 0.7517 | 0.8537 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.05 | 770.25 | 9534 | 10413 | 0.9155 | 0.9536 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.27 | 770.25 | 8138 | 10730 | 0.7584 | 0.8596 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.27 | 770.25 | 9906 | 10730 | 0.9231 | 0.9584 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 74.50 | 770.25 | 8320 | 10991 | 0.7569 | 0.8599 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 74.50 | 770.25 | 10109 | 10991 | 0.9197 | 0.9568 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 76.75 | 770.25 | 8587 | 11262 | 0.7624 | 0.8646 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 76.75 | 770.25 | 10306 | 11262 | 0.9150 | 0.9546 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 78.98 | 770.25 | 8881 | 11518 | 0.7710 | 0.8711 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 78.98 | 770.25 | 10672 | 11518 | 0.9265 | 0.9613 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 81.20 | 770.25 | 9067 | 11766 | 0.7706 | 0.8718 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 81.20 | 770.25 | 10958 | 11766 | 0.9313 | 0.9641 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 83.42 | 770.25 | 9272 | 12031 | 0.7706 | 0.8728 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 83.42 | 770.25 | 11164 | 12031 | 0.9279 | 0.9626 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 85.64 | 770.25 | 9565 | 12287 | 0.7784 | 0.8785 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 85.64 | 770.25 | 11379 | 12287 | 0.9261 | 0.9619 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.86 | 770.25 | 9785 | 12543 | 0.7801 | 0.8803 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.86 | 770.25 | 11514 | 12543 | 0.9179 | 0.9579 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.21 | 770.25 | 750 | 904 | 0.8291 | -0.1085 | MN20160304_L02 | K22 |